CIT Group announced the sale of Amerita, Inc., a provider of home and specialty infusion services, to PharMerica Corporation, an institutional pharmacy services provider. The deal was led by Wesley Smith, Chris Schaefer and Robyn Friedman from CIT Healthcare. CIT Capital Securities acted as the exclusive financial advisor to Amerita. Terms of the transaction were not disclosed.

Amerita was a portfolio company of Ferrer Freeman & Company, a private equity firm focused on the healthcare industry.

“Together, with PharMerica, we look forward to continuing to provide quality services and support to home and specialty infusion patients,” said Jim Glynn, founder and CEO of Amerita.

David Freeman, a FFC Founding Partner, added, “CIT drove a sale process that yielded a great outcome for FFC and Amerita’s equity holders. We are especially pleased that Jim and his team have the opportunity to continue leading the next phase of Amerita’s growth with PharMerica’s support.”